Literature DB >> 3702430

Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa).

C F Holinka, H Hata, H Kuramoto, E Gurpide.   

Abstract

A human endometrial adenocarcinoma cell line (Ishikawa) has been found to be estrogen responsive. The growth stimulatory effects of estradiol (10(-8) M) could be clearly demonstrated when cell cultures containing the hormone were compared with the maximal cell density achieved in control cultures. The approx. 3-fold increase in cell density observed 2-3 weeks after plating, with frequent medium changes, could by blocked by a 100-fold molar excess of the antiestrogen trans-4-monohydroxytamoxifen. When added to hormone-free cultures that had reached a plateau level of cell numbers on day 14 after plating, estradiol (10(-8) M) caused the resumption of proliferation: after 6 days in the presence of the hormone, the cultures contained nearly twice the cell numbers of controls. Effects of estradiol on Ishikawa cells were also evident from the several-fold increases in the levels of specific progesterone binders provoked by the hormone at 10(-9)-10(-6) M concentrations. Cells injected into nude mice formed tumors which contained estrogen and progesterone binders. The availability of a fast-growing (doubling time approx. 30 h) endometrial cancer cell line responsive to estradiol at near physiologic levels will facilitate biochemical studies of hormonal effects on the human endometrium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702430     DOI: 10.1016/0022-4731(86)90036-1

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  10 in total

1.  Transcriptional repression of peri-implantation EMX2 expression in mammalian reproduction by HOXA10.

Authors:  Patrick J Troy; Gaurang S Daftary; Catherine N Bagot; Hugh S Taylor
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Caeruloplasmin biosynthesis by the human uterus.

Authors:  M L Schilsky; R J Stockert; J W Pollard
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

3.  Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.

Authors:  Edith Porter; Huixia Yang; Sujata Yavagal; Gloria C Preza; Omar Murillo; Heriberto Lima; Sheila Greene; Laily Mahoozi; Marcia Klein-Patel; Gill Diamond; Sunita Gulati; Tomas Ganz; Peter A Rice; Alison J Quayle
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

5.  Enhanced estrogen-induced proliferation in obese rat endometrium.

Authors:  Qian Zhang; Qi Shen; Joseph Celestino; Michael R Milam; Shannon N Westin; Robin A Lacour; Larissa A Meyer; Gregory L Shipley; Peter J A Davies; Lei Deng; Adrienne S McCampbell; Russell R Broaddus; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2009-02       Impact factor: 8.661

6.  Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?

Authors:  G Larry Maxwell; Chunqiao Tian; John I Risinger; Chad A Hamilton; Richard R Barakat
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

7.  Dichloroacetate induces apoptosis in endometrial cancer cells.

Authors:  Jason Y Y Wong; Gordon S Huggins; Marcella Debidda; Nikhil C Munshi; Immaculata De Vivo
Journal:  Gynecol Oncol       Date:  2008-04-18       Impact factor: 5.482

8.  Ornithine decarboxylase activity in human endometrium and endometrial cancer cells.

Authors:  C F Holinka; E Gurpide
Journal:  In Vitro Cell Dev Biol       Date:  1985-12

9.  Synergistic estrogenic effects of Fusarium and Alternaria mycotoxins in vitro.

Authors:  Katharina Vejdovszky; Kathrin Hahn; Dominik Braun; Benedikt Warth; Doris Marko
Journal:  Arch Toxicol       Date:  2016-07-11       Impact factor: 5.153

10.  Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines-a survey in Sweden.

Authors:  Sandra Halldorsdottir; Hanna Dahlstrand; Karin Stålberg
Journal:  Ups J Med Sci       Date:  2018-12-10       Impact factor: 2.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.